The company also rebounded from a loss to post A$799m in interim profits.
ANALYSIS: How issuing staff shares can change the picture.
Morningstar’s latest research shows top performance of just 2.9%.
IPO stock priced at US$15 rose to high of US$32.44 before settling back.
Cherri Global to raise up to $15m in share offer.
Ex-FMA head of conduct Colin Magee wants to fill SME funding gap.
Move follows ousting of chair and MD at turbulent AGM.
Documents filed for new global equities fund.
JBWere senior investment analyst Philip Borkin on the week ahead.
Peter Meintjes has track record for commercialising disruptive biotech, company says.